In one study, osteopontin deficiency protected mice from DSS-induced colitis [38], while in another study, osteopontin administration in Opn−/− mice reduced the disease activity index, improved red blood cell counts, and reduced gut neutrophil activity compared with the DSS-treated wildtype mice [37]. This evidence concerns the gene SPP1 and colitis.